Leiomyoma cell growth is dependent on ovarian hormone activity through growth factors.
Growth factors exert their effects activating multiple signal transduction pathways.
Growth factor signaling pathways include Smad 2/3, ERK 1/2, PI3K, and β-catenin.
Therapeutic compounds downregulate growth factors and their signaling pathways.
Growth factors are attractive therapeutic targets for the treatment of fibroids.